May 11, 2016 by Brian FeroldiHere's Why TransEnterix Inc's Shares Are Tanking TodayNews of a strategy shift causes shares to plunge.
May 10, 2016 by Brian FeroldiHere's Why Insys Therapeutics Inc. Fell 14.3% in AprilWarnings of terrible first-quarter results send traders running.
May 10, 2016 by Brian FeroldiHere's Why MannKind Corporation is Down Big TodayShares plunge after the company reports its first-quarter results and announces that they are raising capital.
May 9, 2016 by Brian FeroldiWhy Inovio Pharmaceuticals Inc. Is Soaring TodayInvestors cheer the company's first-quarter results.
May 8, 2016 by Brian FeroldiMerrimack Pharmaceuticals Inc Dropped 18.2% in April Despite Positive DevelopmentsShares tanked even though the company had a handful of positive developments occur during the month.
May 7, 2016 by Brian FeroldiLast Week's Best Healthcare ETFHealthcare-focused investors took a beating this week, but this one ETF held up better than the rest.
May 7, 2016 by Brian FeroldiEylea's Growth Propels Regeneron Pharmaceuticals Inc Shares HigherThe company top-selling eye disease drug continues to grow rapidly, but an increase in spending caused profits to wane.
May 7, 2016 by Brian FeroldiWhy Intra-Cellular Therapies Inc Stock Jump 21.4% in AprilShares bounced back from a rough start to the year after management made the rounds at a handful of investor conferences.
May 7, 2016 by Brian Feroldi, Sean Williams, Evan Niu, CFA, Jason Hall, Neha Chamaria, Andrés Cardenal, and George Budwell, PhD7 Stocks to Buy in MayThe market is back in positive territory for the year, but there are still plenty of buying opportunities out there.
May 6, 2016 by Brian FeroldiIs This The Reason That Omeros Corporation Fell 17.7% in April?News that the company is looking to raise capital from a share offering sends shares lower.
May 6, 2016 by Brian FeroldiWhy MannKind Corporation's Stock Plunged 15.1% in AprilIt was an eventful month for the beleaguered biopharma, but the market remains skeptical about this company's future.
May 6, 2016 by Brian FeroldiWhy Envision Healthcare Holdings Inc Is Soaring TodayInvestors cheer the company's first-quarter earnings report.
May 6, 2016 by Brian FeroldiHere's Why Chimerix Inc Jumped 14.3% in AprilThis once-promising clinical-stage company is trying to prove that it's not dead yet, but investors remain skeptical.
May 5, 2016 by Brian FeroldiHere's Why Keryx Biopharmaceuticals Jumped 18.2% in AprilA solid first-quarter earnings report puts traders in a good mood.
May 5, 2016 by Brian FeroldiAcquisitions Drive CVS Health Inc.'s Q1 Revenue HigherThe pharmacy retail giant posts strong revenue growth during the quarter, but declining margins caused profit growth to remain tepid.
May 4, 2016 by Brian FeroldiWhy Nektar Therapeutics Inc Is Dropping TodayDespite producing an earnings report packed with good news, shares still dropped. Is this a buying opportunity?
May 4, 2016 by Brian FeroldiWhy Glaukos Corp. Is Skyrocketing TodayAn impressive earnings report filled with good news has traders bidding up shares on Wednesday.
May 4, 2016 by Brian FeroldiWhy ACADIA Pharmaceuticals Inc Jumped 12.7% in AprilIt was a transformative month for the clinical-stage biopharma.
May 3, 2016 by Brian FeroldiRegeneron Pharmaceuticals Inc Has a Lot to Prove on May 5All eyes will be on the biotech behemoth's quarterly report this Thursday.
May 3, 2016 by Brian FeroldiWhy Insulet Corporation and Tandem Diabetes Care Both Tanked TodayNews that a competitor won an exclusive deal with a major payer causes shares to drop.
